Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 9 de 9
Health Res Policy Syst ; 21(1): 28, 2023 Apr 06.
Article in English | MEDLINE | ID: covidwho-2247804


Given the many challenges facing healthcare access in many developing countries and the added limitations observed in emergencies like COVID-19 pandemic, the authors here discuss an alternative and feasible approach to overcome all these limitations.

Epidemiologic Methods , Online Social Networking , Registries , Registries/standards , Developing Countries , Internet/standards , Health Services Accessibility , Disease Outbreaks/prevention & control
Trials ; 22(1): 188, 2021 Mar 05.
Article in English | MEDLINE | ID: covidwho-1119438


OBJECTIVE: To assess the registration quality of traditional Chinese medicine (TCM) clinical trials for COVID-19, H1N1, and SARS. METHOD: We searched for clinical trial registrations of TCM in the WHO International Clinical Trials Registry Platform (ICTRP) and Chinese Clinical Trial Registry (ChiCTR) on April 30, 2020. The registration quality assessment is based on the WHO Trial Registration Data Set (Version 1.3.1) and extra items for TCM information, including TCM background, theoretical origin, specific diagnosis criteria, description of intervention, and outcomes. RESULTS: A total of 136 records were examined, including 129 severe acute respiratory syndrome coronavirus 2 (COVID-19) and 7 H1N1 influenza (H1N1) patients. The deficiencies in the registration of TCM clinical trials (CTs) mainly focus on a low percentage reporting detailed information about interventions (46.6%), primary outcome(s) (37.7%), and key secondary outcome(s) (18.4%) and a lack of summary result (0%). For the TCM items, none of the clinical trial registrations reported the TCM background and rationale; only 6.6% provided the TCM diagnosis criteria or a description of the TCM intervention; and 27.9% provided TCM outcome(s). CONCLUSION: Overall, although the number of registrations of TCM CTs increased, the registration quality was low. The registration quality of TCM CTs should be improved by more detailed reporting of interventions and outcomes, TCM-specific information, and sharing of the result data.

COVID-19/therapy , Clinical Trials as Topic , Influenza, Human/therapy , Medicine, Chinese Traditional , Registries/standards , Severe Acute Respiratory Syndrome/therapy , Humans , Influenza A Virus, H1N1 Subtype , Public Health , SARS-CoV-2
Rheumatology (Oxford) ; 60(1): 353-358, 2021 01 05.
Article in English | MEDLINE | ID: covidwho-713732


OBJECTIVES: As the coronavirus disease 2019 pandemic developed there was a paucity of data relevant to people living with rheumatic disease. This led to the development of a global, online registry to meet these information needs. This manuscript provides a detailed description of the coronavirus disease 2019 Global Rheumatology Alliance registry development, governance structure, and data collection, and insights into new ways of rapidly establishing global research collaborations to meet urgent research needs. METHODS: We use previously published recommendations for best practices for registry implementation and describe the development of the Global Rheumatology Alliance registry in terms of these steps. We identify how and why these steps were adapted or modified. In Phase 1 of registry development, the purpose of the registry and key stakeholders were identified on online platforms, Twitter and Slack. Phase 2 consisted of protocol and data collection form development, team building and the implementation of governance and policies. RESULTS: All key steps of the registry development best practices framework were met, though with the need for adaptation in some areas. Outputs of the registry, two months after initial conception, are also described. CONCLUSION: The Global Rheumatology Alliance registry will provide highly useful, timely data to inform clinical care and identify further research priorities for people with rheumatic disease with coronavirus disease 2019. The formation of an international team, easily able to function in online environments and resulting in rapid deployment of a registry is a model that can be adapted for other disease states and future global collaborations.

Biomedical Research/organization & administration , COVID-19 , Data Collection/methods , Internet , Registries/standards , Rheumatic Diseases , Rheumatology , Biomedical Research/methods , Humans , Implementation Science , Internationality , SARS-CoV-2 , Social Media , Stakeholder Participation